Diabetes care devices are used to monitor and control blood glucose levels in diabetic patients. The main types of diabetes care devices are blood glucose test strips, insulin pens, syringes, pumps and injectors, lancing devices and equipment, continuous glucose monitoring devices and equipment, and blood glucose meters. Insulin pens are injection devices with a needle that delivers insulin into the subcutaneous tissue. The type of expenditures is public and private. The products used are instruments/equipment and disposables. The various end-users are hospitals and clinics, diagnostic laboratories, and others. The diabetes care devices market research report is one of a series of new reports from The Business Research Company that provides diabetes care devices market statistics, including diabetes care devices industry global market size, regional shares, competitors with a diabetes care devices market share, detailed diabetes care devices market segments, market trends and opportunities, and any further data you may need to thrive in the diabetes care devices industry. This diabetes care devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global diabetes care devices market grew from $58.63 billion in 2022 to $62.94 billion in 2023 at a compound annual growth rate (CAGR) of 7.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The diabetes care devices market is expected to grow to $80.06 billion in 2027 at a CAGR of 6.2%. Busy lifestyles and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as diabetes. Long working hours, limited physical activity, and unhealthy eating and drinking habits are major causes of diabetes. For instance, according to WHO data 2021, more than 95% of people with diabetes have type 2 diabetes. According to a World Health Organization (WHO) report, 74% of men and 64% of women in the UK, for instance, are expected to be overweight by 2030. These factors are expected to increase the patient pool of diabetes. For instance, according to IDF data 2021, nearly 537 million adults (20-79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. These factors are expected to aid the market growth in the forecast period. The diabetes care devices market is expected to be limited by the high cost of the equipment, especially in low-income countries, where the cost related to diabetes devices is very high, despite insurance coverage. For example, in the US all the expenses related to diabetes treatment, which includes diabetes care devices can reach $1,000 a month. Thus, high costs associated with diabetes care devices and their accessories are likely to impede the market growth going forward. Pharmaceutical companies are investing in developing and commercializing glucose-responsive insulins (GRIs), providing significant opportunities for the development of new types of insulin delivery devices. For example, Novo Nordisk, a Danish pharmaceutical company, has planned to develop GRIs by acquiring UK biotech start-up Ziylo with an investment of $800 million. Companies such as Eli Lily and Sanofi have also planned research projects to develop GRIs. GRIs are 'smart' insulins that automatically activate or deactivate in response to changing glucose levels in the blood. They improve diabetes treatment efficacy and reduce the incidence of hyperglycemia and hypoglycemia. Major companies in the diabetes care devices market include Abbott Laboratories, Novo Nordisk, Medtronic Inc., Dexcom, Inc., F. Hoffmann-La Roche Ltd., Becton Dickinson, Insulet, Ypsomed, ConvaTec Group Plc, and B. Braun Group. North America was the largest region in the global diabetes care devices market in 2022. Western Europe was the second largest region in the global diabetes care devices market. The regions covered in the diabetes care devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the diabetes care devices market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The diabetes care devices market consists of sales of blood glucose monitoring devices, insulin delivery devices, smart insulin pens and others that are used for monitor and treat diabetes patient. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global diabetes care devices market is segmented - 1) By Type: Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables Subsegments Covered: Glucose Dehydrogenase, Glucose Oxidase, Pens, Injectors And Pumps, Syringes

Digital diabetes management refers to using electronic medical solutions to monitor, analyze, and manage diabetics remotely. People with diabetes or those who are at risk for developing it can improve their health outcomes by successfully managing their condition on their own with the help of digital diabetes management. The main types of products and services in digital diabetes management are devices, application, data management software & platforms, services. A data management platform (DMP) is a piece of software that collects and manages data. They enable companies to create audience segments that can then be utilized to target certain individuals and settings in online advertising campaigns. The different types of devices include handheld devices, wearable devices and used in various sectors such as self or home healthcare, hospitals and specialty diabetes clinics, others. The digital diabetes management market research report is one of a series of new reports from The Business Research Company that provides digital diabetes management market statistics, including digital diabetes management industry global market size, regional shares, competitors with a digital diabetes management market share, detailed digital diabetes management market segments, market trends and opportunities, and any further data you may need to thrive in the digital diabetes management industry. This digital diabetes management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global digital diabetes management market size will grow from $10.82 billion in 2022 to $13.25 billion in 2023 at a compound annual growth rate (CAGR) of 22.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global digital diabetes management market size is expected to grow to $30.11 billion in 2027 at a CAGR of 22.8%. The increasing prevalence of diabetes is projected to propel the demand for digital diabetes management devices and related services, thereby increasing the demand for the market. Diabetes is a leading cause of death, with 30% of loss of life expectancy coming from the diagnosis of diabetes. In 2021, according to the International Diabetes Federation, a total of 537 million individuals (20-79 years old) worldwide had diabetes and according to projections, there will be 643 million diabetics worldwide by 2030 and 783 million by 2045. Data security is a major challenge limiting the growth of the digital diabetes management market. Data safety is necessary to maintain integrity and confidentiality. A lack of accurate flow of information and commands is likely to compromise the function of digital diabetes devices and may put patients or users at the risk of health complications. For instance, according to Hippa Journal, the official publication of the American Health Information Management Association, the Office for Civil Rights (OCR) of the Department of Health and Human Services (HHS) received 347 reports of healthcare data breaches involving 500 or more records between January 1, 2022, and June 30, 2022. Several companies are increasing attention on developing design-focused and AI-powered connected apps to enhance the user experience, which is gaining significant popularity in the digital diabetes management market. Key companies operating in the digital diabetes management market including OneDrop, Ascencia, and Dario are increasing their focus on developing their products as stylish gadgets rather than medical devices. For instance, Medtronic plc and IBM Watson Health announced the launch of AI-powered Sugar.IQ smart diabetes management app, designed to improve and simplify daily diabetes management. In April 2020, OneDrop, a consumer diabetes management platform, announced the acquisition of assets, IP, and certain staff of Sano Intelligence Inc., an innovator in health sensing technology, for an undisclosed amount. OneDrop and Sano Intelligence shared a vision of transforming traditional healthcare into preventive and proactive self-care. The companies are expected to integrate Sano’s silicon sensing technology into a painless silicon-based health sensing platform for use across multiple conditions, which is a personalized solution for a rapidly growing health issue. Sano Intelligence, Inc. was founded in 2011 and is a manufacturer of non-invasive connected CGM patch. Major players in the digital diabetes management market are Bayer AG, Medtronic, Roche Diagnostics, Dexcom, Inc., Abbott Laboratories, Ascensia Diabetes Care, Insulet Corporation, B. Braun Melsungen AG, Tandem Diabetes Care and LifeScan Inc. North America was the largest region in the digital diabetes management market in 2022. Western Europe was the second largest region in the global digital diabetes management market. The regions covered in the global digital diabetes management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the digital diabetes management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The digital diabetes management market consists of revenue generated by the companies offering devices and services that manage blood glucose levels in the human body. These devices play a vital role in the care of diabetes patients with the management of patients' blood glucose levels and controlling their conditions. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global digital diabetes management market is segmented - 1) By Product & Service: Devices, Application, Data Management Software & Platforms, Services 2) By Device Type: Handheld Devices, Wearable Devices 3) By End User: Self/Home Healthcare, Hospitals & Specialty Diabetes Clinics, Other End Users

Blood glucose meters are devices that are used to measure and display the amount of sugar (glucose) in the blood. The main product types of blood glucose meters market are electrode type blood glucose meter and the photoelectric blood glucose meter. Electrode type blood glucose meters are devices that contain electrodes to measure the current generated by an enzymatic reaction between glucose, an enzyme, and a mediator. The various applications included are type 1 diabetes, type 2 diabetes, and gestational diabetes, which are used by various end-users such as hospitals and home care. The blood glucose meters market research report is one of a series of new reports from The Business Research Company that provides blood glucose meters market statistics, including blood glucose meters industry global market size, regional shares, competitors with a blood glucose meters market share, detailed blood glucose meters market segments, market trends and opportunities, and any further data you may need to thrive in the blood glucose meters industry. This blood glucose meters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global blood glucose meters market size will grow from $15.64 billion in 2022 to $16.96 billion in 2023 at a compound annual growth rate (CAGR) of 8.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The blood glucose meters market size is expected to grow to $22.34 billion in 2027 at a CAGR of 7.1%. The rising prevalence of diabetes is driving the blood glucose meters market. The changing lifestyle, increase in alcohol consumption, physical inactivity, and unhealthy eating habits are leading to an increase in obesity across the globe. Such exponential growth in obese people is causing a stern increase in the purchase of blood glucose meters. Due to obesity, fat tissues release more fat molecules into the blood affecting insulin-responsive cells, which results in reduced insulin sensitivity, in turn, causing diabetes. According to the study by the International Diabetes Federation (IDF), there will be a 48% increase in diabetes around the world by 2045. According to the International Diabetes Federation (IDF) in 2021, nearly 537 million people were suffering from diabetes. The blood glucose meters market growth is restricted due to a lack of awareness of diabetes. Hypo unawareness is a common term used to describe people who have diabetes, especially type 1 diabetes, it is very difficult to notice when they have low blood glucose, hypoglycemia. Such lack of awareness of diabetes and its effects reduces the regular monitoring or check-ups relating to diabetes. For example, in 2021, 537 million adults had diabetes, but more than 1 in 4 did not know that they had the disease. Also, in 2021, According to the International Diabetes Federation (IDF), over one in two (54%) patients with diabetes do not recognize that they have diabetes. The launch of new products is a key trend gaining popularity in the blood glucose meters market. Companies in the market are focusing on the launch of new products to improve their product portfolio and strengthen their market position. For example, in January 2022, Roche, a Swiss multinational healthcare company, launched its new point-of-care blood glucose monitor designed for hospital professionals, with a companion device shaped like a touchscreen smartphone that will run its own apps. Glytec, a US based insulin management software company supplied software for the device, its Glucommander insulin-dosing program to help streamline the complex task of managing blood sugar levels during a patient's hospital stay. FDA regulates blood glucose meters. FDA has released its guidance for the accuracy of blood glucose meters. For blood glucose meters used in the home by patients with diabetes, FDA states that 95% of the measured blood glucose levels should be within 15% of the lab tested value and 99% of the measured values should be within 20% of the lab tested value. For the point of care blood glucose monitoring devices, 95% of the monitored values must be within the range of 12% for blood sugars more than 75mg/dl and must be within 12mg/dl for blood sugars less than 75mg/dl. Also, 98% of the meter values must be within 15% of the range for blood sugars more than 75mg/dl and must be within 15mg/dl for blood sugars less than 75mg/dl. In September 2021, B. Braun Melsungen AG, a German medical and pharmaceutical device company acquired Sterinova Inc for an undisclosed amount. This acquisition of Sterinova will continue to operate as a distinct subsidiary of B. Braun Melsungen AG. Sterinova Inc is a Canada-based company that develops, manufactures, and distributes ready-to-use sterile injectable products in syringes and premix bags. Major players in the blood glucose meters market are Abbott, Roche, Medtronics, Ascensia, Dexcom, Johnson & Johnson, Arkray, Acon, LifeScan, and Agamatrix Inc. North America was the largest region in the global blood glucose meters market in 2022. Western Europe was the second-largest region in the blood glucose meters market. The regions covered in the global blood glucose meters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries in the blood glucose meters market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia. The blood glucose meters consist of sales of electrode-type blood glucose meter and photoelectric blood glucose meter. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global blood glucose meters market is segmented - 1) By Product type: Electrode Type Blood Glucose Meter, Photoelectric Blood Glucose Meter 2) By End User: Hospitals, Home Care 3) By Application: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes

Insulin drugs refer to medications that used to treat diabetes. Insulin is a medication prescribed to treat type 1 diabetes and type 2 diabetes mellitus. There are several types, preparations, and dosage amounts of insulin. Insulin is a hormone that is produced naturally in our bodies. Its main role is to allow cells throughout the body to uptake glucose (sugar) and convert it into a form that can be used by these cells for energy. The main product types of insulin drugs are prandial insulins, basal insulins, premixed insulins, and other insulins. A meal is referred to as a prandial. Postprandial (from post prandium) refers to the time after a meal, whereas preprandial refers to the time before a meal. The drugs are classified into branded drugs and generic drugs that are distributed by hospital pharmacies, retail pharmacies, drug stores, and others. The various applications include type II diabetes, type I diabetes, gestational diabetes, and prediabetes. The insulin drugs market research report is one of a series of new reports from The Business Research Company that provides insulin drugs market statistics, including insulin drugs industry global market size, regional shares, competitors with an insulin drugs market share, detailed insulin drugs market segments, market trends and opportunities, and any further data you may need to thrive in the insulin drugs industry. This insulin drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global insulin drugs market size will grow from $32.83 billion in 2022 to $36.50 billion in 2023 at a compound annual growth rate (CAGR) of 11.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global insulin drugs market size is expected to grow to $53.41 billion in 2027 at a CAGR of 10.0%. Changing lifestyles are leading to a higher prevalence of diabetes. This is expected to drive the demand for diabetes drugs during the forecast period. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of diabetes. According to a study, there was a high prevalence of diabetes in people with sedentary lifestyles. Additionally, people suffering from obesity are up to 80 times more likely to develop type 2 diabetes. According to a World Health Organization (WHO) report, 74% of men and 64% of women in the UK, for instance, are expected to be overweight by 2030. These factors are expected to increase the patient pool of diabetes, thereby likely to drive the diabetes therapies market during the forecast period. High costs and long payback periods for investment in new diabetes drugs negatively impacted the market during the forecast period. The costs for drug approval processes that include multiple phases of clinical trials and screening processes with regulatory bodies such as the US FDA are very high. According to a study published in the journal JAMA, the cost of bringing a new drug from its conception to shelves was about $2.8 billion in 2020. These high costs and uncertainty regarding return on investments for drug development limited the investments by pharmaceutical companies in the development of new diabetic drugs, thus limiting the growth of the market during the historic period. There is an increasing trend of mergers and acquisitions for new formulations in the Insulin market and companies are investing in the development of new medicines in the insulin drugs market. For example, researchers at Lund University Diabetes Centre in Sweden, worked on CRISPR, a genome modification tool. This resulted in the turning off of one of the genes which were responsible for causing diabetes. This effectively decreased beta cell death and increased insulin production in the pancreas. Insulin maker, Novo Nordisk has developed a diabetes pill and planned to launch it in India by February 2022. This pill belongs to a blockbuster class of drugs, glucagon-like peptide-1 (GLP-1s) that stimulate insulin production. The new drug is expected to generate about $5 billion in annual sales. In July 2021, Eli Lilly and Company, a US-based pharmaceutical company specialising in the discovery, development, manufacturing, and commercialization of human drugs, acquired Protomer Technologies Inc. for an amount of $1 billion. Through this acquisition, Lilly enhances its capabilities to make the lives of diabetes patients better, and we're still committed to offering practical solutions, such as advancements in insulin therapy. The development of glucose-sensing insulin, which has the potential to significantly enhance both the therapeutic efficacy and safety of insulin therapy, is the next step in diabetes care. Protomer Technologies Inc. is a US-based pre-clinical stage biotechnology company pioneering in research and technology development for the treatment of metabolic disorders. Major players in the insulin drugs market are Apidra, Eli Lilly, Humalog, Humulin, Insuman, Lantus, Levemir, Novo Nordisk, Novomix, NovoRapid/Novolog, Actrapid, Admelog, Novolin/Actrapid/Insulatard, Ryzodeg, Sanofi, Soliqua/Suliqua, Toujeo, Tresiba, and Xultophy. North America was the largest region in the insulin drugs market in 2022. The Middle East is expected to be the largest growing region in the global insulin drugs market during the forecast period. The regions covered in the global insulin drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The insulin drugs market consists of sales of rapid-acting insulin, short-acting insulin, and mixed insulin. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global insulin drugs market is segmented - 1) By Product Type: Prandial Insulins, Basal Insulins, Premixed Insulins, Other Insulins 2) By Application: Type II Diabetes, Type I Diabetes, Gestational Diabetes, Prediabetes 3) By Drug Classification: Branded Drugs, Generic Drugs 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drugs Stores, Other Distribution Channels

Diabetic footwear refers to therapeutic footwear that is broader and deeper than conventional shoes and made of special protective inserts and soft materials. It includes a larger toe box to avoid squeezing the toes and reduce the possibility of bottom blisters (ulcers) produced by disunion and pressure. The diabetic footwear is used to relieve pressure and calluses on the bottom of the foot. The main types of diabetic footwear are shoes, sandals, and slippers. The diabetic shoes are made of special protective inserts and soft materials and are used for increasing blood circulation and nerve sensation, having a wide toe box, and massaging to reduce pressure. The various distribution channels include online platforms, specialty stores, footwear stores, and others and are used by various end-users, including men, women. The diabetic foot wear market research report is one of a series of new reports from The Business Research Company that provides diabetic foot wear market statistics, including global market size, regional shares, competitors with a diabetic foot wear market share, detailed diabetic foot wear market segments, market trends and opportunities, and any further data you may need to thrive in the diabetic foot wear industry. This diabetic foot wear market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry. The global diabetic footwear market size grew from $7.1 billion in 2022 to $7.83 billion in 2023 at a compound annual growth rate (CAGR) of 10.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The diabetic footwear market size is expected to grow to $10.67 billion in 2027 at a CAGR of 8.1%. The increase in the number of diabetic patients will propel the growth of the diabetic footwear market going forward. Diabetes is a chronic health condition that results in high blood glucose levels. Diabetic footwear can help prevent serious foot health complications that can arise as a result of diabetes and also provide the necessary benefits such as increased blood circulation, a wide toe box, and massaging to reduce pressure in the areas of the foot that are most susceptible to pain. For instance, in 2021, according to the report published by the International Diabetes Federation, a Belgium-based umbrella organization of 230 national diabetes associations, there were 463 million and 537 million people suffering from diabetes around the world in 2019 and 2021, respectively. Also, by 2030, the overall number of diabetics is expected to reach 643 million, and by 2045, it will reach 783 million. Therefore, the increasing number of diabetic patients is driving the growth of the diabetic footwear market. Technological advancements are a key trend gaining popularity in the diabetic footwear market. Major companies operating in the diabetic footwear market are developing new technologies to strengthen their position in the market. For instance, in December 2021, Von Wellx, a Germany-based company that specializes in footwear that provides health benefits, launched diabetic footwear based on reflex zones technology. The footwear functions by massaging the pressure points in the foot, similar to walking barefoot on grass, stimulating blood circulation and oxygen, thereby energizing the body and resulting in minimal exhaustion throughout the day, even when standing and walking for 12 hours or more. It also gives the benefit of walking 8000 steps with only 3000 steps because the spring and massaging function work the user's foot muscles 2.5 times per step. In November 2021, Aiglon Capital and Merit Capital, a US-based private infrastructure firm, acquired Propét for an undisclosed amount. The acquisition is anticipated to improve the position, provide Aiglon and Merit with a solid base, and open up new opportunities for brand expansion. Propet is a US-based company that manufactures comfort footwear and diabetic footwear. Major players in the diabetic footwear market are Podartis Srl, DJO Global Inc., Aetrex Worldwide Inc., Dr. Zen Products Inc., Orthofeet Inc., Dr. Comfort llc, Drew Shoes, New Balance Inc., I-Runner, Finn Comfort, Pilgrim shoes, Diabetic Soles Inc., Hanger Inc., and Hush Puppies Retail Inc. North America was the largest region in the diabetic footwear market in 2022. The regions covered in the diabetic footwear market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the diabetic footwear market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The diabetic footwear market consists of sales of in-depth shoes, healing shoes, and custom-made shoes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global diabetic footwear market is segmented - 1) By Type: Shoes, Sandals, Slippers 2) By Distribution Channel: Online Platform, Specialty Stores, Footwear Stores, Other Distribution Channles 3) By End User: Men, Women

Stevia is a non-nutritive or zero-calorie sugar substitute made of steviol glycosides from the leaves of the stevia plant. It has no artificial ingredients and can be used as a natural sugar alternative to reduce calorie consumption. The main types of products of stevia are powder, liquid, and leaf. Powdered stevia is used in place of table sugar in food and beverages which is equal to about one teaspoon of table sugar. Stevia is available in organic and conventional forms and is used in bakeries, dairy food products, beverages, dietary supplements, confectionery, others. The stevia market research report is one of a series of new reports from The Business Research Company that provides stevia market statistics, including stevia industry global market size, regional shares, competitors with a stevia market share, detailed stevia market segments, market trends and opportunities, and any further data you may need to thrive in the stevia industry. This stevia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global stevia market size grew from $0.75 billion in 2022 to $0.82 billion in 2023 at a compound annual growth rate (CAGR) of 9.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The stevia market size is expected to grow to $1.3 billion in 2027 at a CAGR of 12.1%. The rising prevalence of diabetes and obesity is expected to propel the growth of the stevia market in the forecast period. The main causes leading to obesity are unhealthy lifestyle, physical inactivity, overeating, genetics, increase in stress levels which rises the risk of diabetes, heart disease, and certain cancers. According to the International Diabetes Federation (IDF), almost 463 million people worldwide had diabetes in 2020 and it is estimated that nearly 5.3 million individuals will be living with the disease by 2025. According to the World Obesity report, it is expected that 1 in 5 adults worldwide to have obesity by 2025, and the obesity prevalence is predicted to reach 18% in men and surpass 21% in women. As the prevalence of diabetes and obesity rises, customers are looking for zero-calorie natural sweeteners to help them maintain a healthy lifestyle and keep their blood sugar levels in check. Thus, the demand for stevia is estimated to increase, driving the growth of the market. The development of innovative product variants of stevia is a key trend gaining popularity in the stevia market. Major companies in the market are shifting towards product innovations to strengthen their position in the market and expand their product portfolios. Successful invention fosters additional development, allowing the company to scale and flourish while also ensuring that it meets the needs of its customers. For example, in February 2020, Socati, an Italian company that processes and manufactures pharmaceutical products announced the release of its CBD coffee brightener and CBD coffee sweetener, which uses stevia and monk fruit as sweeteners. The coffee sweetener is a quick-dissolving powder stick pack flavored with Madagascar vanilla and brown sugar. In April 2020, Ingredion, a US-based food company offering stevia acquired Pure circle for an undisclosed amount. Through this acquisition, PureCircle is likely to benefit from Ingredion's global distribution network, as well as its formulation ability and diverse product portfolio, resulting in growth benefits and considerable cost savings for both firms. Pure circle is a US-based company that produces stevia sweeteners for the food and beverage industry. Major players in the stevia market are GLG Life Tech Corp., Ingredion Incorporated, Tate & Lyle PLC, The Coca-Cola Company, PepsiCo Inc., Cargill Inc., Evolva Holding S.A., Stevia Corp., ADM, PureCircle Ltd., Sweet Green Fields LLC, Biosweet Ventures, Shandong Aojing Biotechnology Co. Ltd., Sunrise Nutrachem Group Co. Ltd., and Hunan Nutramax Inc. Asia-Pacific was the largest region in the stevia market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stevia report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the stevia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The stevia market consists of sales of powdered stevia, leaf stevia, and liquid stevia that is used as a natural sweetener for food and beverages. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global stevia market is segmented - 1) By Product: Powder, Liquid, Leaf 2) By Nature: Organic, Conventional 3) By Application: Bakery, Dairy Food Products, Beverages, Dietery supplements, Confectionery, Other Applications

Natural sweeteners are sugar substitutes that are refined and prepared using methods such as boiling, mixing, pH adjustment, filtration, and fermentation. They are used to improve the palatability and shelf life of food products and have the potential to make the food both nutritional and flavorful. The main types of natural sweeteners are stevia, sorbitol, xylitol, mannitol, erythritol, sweet proteins, and others. Stevia is a type of natural sweetener that is manufactured from a leaf related to popular garden flowers like asters and chrysanthemums. The different applications include bakery goods, sweet spreads, confectionery, and chewing gums, beverages, dairy products, others and used by various sectors such as food and beverages, pharmaceutical, direct sales, others. The natural sweeteners market research report is one of a series of new reports from The Business Research Company that provides natural sweeteners market statistics, including natural sweeteners industry global market size, regional shares, competitors with a natural sweeteners market share, detailed natural sweeteners market segments, market trends and opportunities, and any further data you may need to thrive in the natural sweeteners industry. This natural sweeteners market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global natural sweeteners market size grew from $5.37 billion in 2022 to $5.8 billion in 2023 at a compound annual growth rate (CAGR) of 8.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The natural sweeteners market size is expected to grow to $7.38 billion in 2027 at a CAGR of 6.2%. The increasing prevalence of diabetes and obesity is expected to propel the growth of the natural sweeteners market in the coming years. A large portion of the population is choosing low sugar options to manage their diabetes and obesity conditions. Many individuals are switching from refined table sugar and high-fructose corn syrup to natural sweeteners because they are a healthier alternative to refined sugars and can help people lose weight. For instance, in 2022, Centers for Disease Control and Prevention, a US-based national public health agency, around 37.3 million people are suffering from diabetes which equals 11.3% of the United States population. Additionally, according to the International Diabetes Federation’s December 2021 report, a Belgium-based leading global diabetes community approximately 537 million adults are suffering from diabetes globally, whereas 3 out of 4 adults are in low- and middle-income countries. Therefore, the increasing prevalence of diabetes and obesity drives the growth of the natural sweeteners market. The growing product innovations are shaping the natural sweeteners market. Major companies operating in the natural sweeteners sector are focused on developing product innovations to strengthen their position. For instance, in 2020, DouxMatok, an Israel-based sweetener-alternative start-up launched Incredo Sugar using proprietary technology. Incredo Sugar, which is created from actual cane or beet sugar is a unique solution for sugar reduction as it allows food products to be reduced in sugar by up to 50%. In December 2020, Whole Earth Brands, Inc., a US-based food company brand acquired Wholesome Sweeteners for an undisclosed amount. The acquisition broadens whole earth's diverse portfolio of trusted brands and delectable products, which meet rising consumer requirements for natural and plant-based dietary options, baking ingredients, and flavor profiles. Wholesome Sweeteners Incorporated is a US-based company that focuses on organic sweeteners. Major players in the natural sweeteners market are ABF Ingredients, Archer-Daniels-Midland, Cargill Inc., DuPont Nutrition & Biosciences, FoodChem International Corporation, Galam Ltd., GLG Life Tech Corp, Herboveda, Imperial Sugar, Ingredion Incorporated, Madhava Foods, Merisant, Morita Kagaku Kogyo Co. Ltd., Ohly, PureCircle Ltd., Roquette Frères, Sunwin Tech Group Inc., SweetLeaf Stevia, Tate & Lyle PLC, Associated British Foods PLC., Fooditive B.V., Hearthside Food Solutions LLC, Nestle SA, and Wilmar International Limited. North America was the largest region in the natural sweeteners market in 2022. The regions covered in the natural sweeteners report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the natural sweeteners market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The natural sweeteners market consists of sales of unprocessed honey, maple syrup, agave nectar, and other natural sweeteners. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global natural sweeteners market is segmented - 1) By Type: Stevia, Sorbitol, Xylitol, Mannitol, Erythritol, Sweet Proteins, Other Types 2) By Application: Bakery Goods, Sweet Spreads, Confectionery And Chewing Gums, Beverages, Dairy Products, Other Applications 3) By End-User: Food And Beverages, Pharmaceutical, Direct Sales, Other End-Users

Foods are defined as processed products of plants, and animals that contain essential nutrients such as protein, carbohydrates, fat, and other nutrients consumed by humans. Beverages are defined as potable drinks which have thirst quenching refreshing, stimulating, and nourishing properties. The main type of food and beverages are alcoholic – beverages, nonalcoholic – beverages, grain products, bakery & confectionary, other foods products, frozen, canned, and dried food, dairy food, meat, poultry and seafood, syrup, seasoning, oils, & general food, animal and pet food, and tobacco products. Alcoholic beverages include beverages that contain varying amounts of alcohol (ethanol). The various typesdistinct types of distribution channels are supermarkets/hypermarkets, convenience stores, e-commerce, and Other Distribution Channels. The different typesseveral types of nature include organic and conventional. The food and beverages research report is one of a series of new reports from The Business Research Company that provides food and beverages statistics, including food and beverages industry global market size, regional shares, competitors with food and beverages share, detailed food and beverages segments, market trends and opportunities, and any further data you may need to thrive in the food and beverages industry. This food and beverages research report deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global food and beverages market grew from $6,729.54 billion in 2022 to $7,221.73 billion in 2023 at a compound annual growth rate (CAGR) of 7.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The food and beverages market is expected to grow to $9,225.37 billion in 2027 at a CAGR of 6.3%. Many countries across the globe are experiencing falling prices of crops due to overcapacity; this is expected to result in low raw material costs for food and beverage companies. For instance, in November 2022, according to the report Frontline, an India-based national magazine on agriculture, the bailout package of Rs 7000 crore, announced by the Cabinet Committee on Economic Affairs, for farmers involved in the sugar production sectors to fix the minimum selling price of refined sugar of Rs 29 per kilogram (prices dropped to Rs 23-24 recently due to overproduction and to create a buffer stock of 3 million tonnes of sugar for one year. Thus, the overproduction of certain crops is likely to result in higher profit margins for food and beverage companies. Higher profit margins will enable food and beverage companies to increase their productivity and drive the market going forward. The outbreak of COVID-19 disease (COVID-19) has acted as a massive restraint on the food and beverages market in 2020 as supply chains were disrupted due to trade restrictions and consumption declined due to lockdowns imposed by governments globally. COVID-19 is an infectious disease with flu-like symptoms including fever, cough, and difficulty in breathing. The virus was first identified in 2019 in Wuhan, Hubei province of the People’s Republic of China, and spread globally including Western Europe, North America, and Asia. Food and beverage manufacturers depend on the supply of raw materials from domestic and international suppliers. As many governments restricted the movement of goods across countries and locally, manufacturers had to halt production due to a lack of raw materials. Also, restrictions on the trade of non-essential goods and fear of contamination through manufacturing facilities contributed to the decline. The outbreak had a negative impact on businesses throughout 2020 and into 2021. However, it is expected that the food and beverages market will recover from the shock across the forecast period as it is a 'black swan event and not related to ongoing or fundamental weaknesses in the market or the global economy. Frozen food manufacturers are using technologies such as individual quick freezing (IQF) to improve the yield and quality of frozen foods. The IQF method involves transferring the individual food items on a conveyor belt into a blast freezer that quickly freezes the items. With the IQF method, every individual piece of food is frozen separately, as opposed to bulk or block freezing. This method boosts yield by 1.5-3% and results in better quality products with high nutritional value and less wastage. Examples of IQF foods include fruits such as blueberries, strawberries, and peaches, and vegetables such as corn, peas, and green beans. The global IQF vegetable market is expected to reach $2 billion by 2026, thus indicating significant demand for IQF food products in the future. Major companies in the food and beverages market include Nestle S.A., JBS S.A., PepsiCo Inc., Anheuser-Busch InBev sa/nv, Tyson Foods Inc., Wilmar International Ltd., Archer-Daniels-Midland Company (ADM), The Coca-Cola Company, Imperial brands plc, Mars Incorporated. Asia-Pacific was the largest region in the food and beverages market in 2022. Western Europe was the second-largest region of the food and beverages market. The regions covered in the food and beverages market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the food and beverages market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The food and beverages market consists of sales of beer, wine and brandy, spirits, coffee and tea, soft drink and ice, flour, rice and malt, breakfast cereal, sugar and confectionery products, bread and bakery products, cookie, cracker, pasta, and tortilla, perishable prepared food, snack food, frozen food, canned and ambient food, milk and butter, cheese, dry, condensed, and evaporated dairy products, ice cream and frozen dessert, meat products, poultry, seafood, flavoring syrup and concentrate, seasoning and dressing, fats and oils, pet food, animal food, cigarettes, cigars and cigarillos, smoking and other tobacco products. The companies in the food and beverages industry process raw materials into food, pet food and tobacco products, package and distribute them through various distribution channels to both on-trade and off-trade establishments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global food and beverages market is segmented - 1) By Type: Alcoholic - Beverages, Non Alcoholic - Beverages, Grain Products, Bakery & Confectionary, Other Foods Products, Frozen, Canned and Dried Food, Dairy Food, Meat, Poultry And Seafood, Syrup, Seasoning, Oils, & General Food, Animal And Pet Food, Tobacco Products 2) By Distribution Channel: Supermarkets/Hypermarkets, Convenience Stores, E-Commerce, Other Distribution Channels 3) By Nature: Organic, Conventional Subsegments Covered: Beer, Wine And Brandy, Spirits, Coffee And Tea, Soft Drink And Ice, Flour, Rice And Malt, Other Grain Products, Breakfast Cereal, Sugar And Confectionery Products, Bread And Bakery Products, Cookie, Cracker, Pasta, And Tortilla, Perishable Prepared Food, Snack Food, All Other Miscellaneous Food, Frozen Food, Canned And Ambient Food, Milk And Butter, Cheese, Dry, Condensed, And Evaporated Dairy Products, Ice Cream And Frozen Dessert, Meat Products, Poultry, Seafood, Flavoring Syrup And Concentrate, Seasoning And Dressing, Fats And Oils, Pet Food, Animal Food, Cigarettes, Cigars And Cigarillos, Smoking And Other Tobacco Products